CEO & BOARD

Daniel works with life science executives to design strategies, operating models, and transformation programs. He brings both functional depth and board-level perspectives, helping senior leaders navigate complexity and make clear choices. He formerly led the life science practice at Deloitte Denmark.

Jonas is a life science strategist supporting executives drive progress across the value chain. He is an expert in bridging strategy and execution via global operating model design and transformation rooted in strategic objectives. He engages with structured top-down thinking and a pragmatic and collaborative approach to mobilise organizations and make things happen.

Jens is a seasoned strategy advisor with 30 years of experience in management consulting. Former Head of Monitor Deloitte Denmark, he brings deep expertise in shaping corporate agendas, TA strategies, operating model design, digital and AI value creation, and M&A for leading global corporations.

Nicolai is a seasoned management consultant with over 20 years of experience working with C-suite executives at Danish C25 companies. He has held several leadership roles, including Senior Partner and Nordic Lead for Monitor Deloitte and Managing Director of Accenture Denmark.

Alexander has 25 years of experience as an international strategy and communications advisor, supporting C-suite leaders at global biopharmaceutical companies on life science branding, digital strategy, and commercialisation. He is founder of the strategic advisory firm &Now, and co-founder of the communications firm REPUTATION.

Camilla brings nearly 30 years of global pharmaceutical leadership, holding senior roles at AstraZeneca, Novartis, Allergan, Alexion, Theramex, and most recently EVP, President, International at Ascendis. Her career spans global commercial and executive leadership roles.

Florian combines experience from strategy consulting and the pharmaceutical industry with a background in Economics from CBS. Recognised for structured problem-solving and a collaborative approach, he supports clients on strategic topics across the pharmaceutical value chain.

Johannes has 7+ years of experience in strategy consulting and has strong expertise in TA strategy, organisational transformations, operating model design, and commercial launch planning. 

Johannes holds an M.Sc. in Economics from the University of Copenhagen.

Mette blends medical expertise with strategic experience as a medical doctor and former strategy consultant. Before joining Biobridge Partners, she worked at Bain & Company and LEO Innovation Lab. She focuses on cross-functional engagement in medical and commercial functions in pharma.

Alfred is a seasoned life science strategy consultant with a background from Monitor Deloitte and 3+ years’ experience helping clients articulate and assess strategies, develop strategic options, and translate strategic intent into actionable plans.

Josephine holds M.Sc. degrees in Biochemistry (University of Copenhagen) and Bioscience Enterprise (UCL), combining life science expertise with business. She has prior consulting experience at Bain & Company, advising clients across multiple industries.

Amadou brings a cross-disciplinary background in Biotechnology and Business Administration. He has experience in strategic projects spanning the full pharmaceutical value chain, from early research to development and commercial strategy.

Daniell leads marketing at Biobridge Partners, helping shape the firm’s positioning, narrative, and go-to-market execution across brand and thought leadership. He brings a background in design and concept development, including experience as a product designer on the health app SELF and 3 years leading marketing at BASE life science.

Caroline brings a strong international background and a passion for life science and its potential for impact. She is pursuing a B.Sc. in International Business at CBS, with a growing focus on strategy, market access, and business development in the life sciences sector.

 Anton is a life science strategy consulting intern with a cross-disciplinary background in molecular medicine and business administration. He has hands-on experience in gene and cell therapy research and focuses on translating scientific innovation into real-world impact through strategic insight.

Bertram brings prior experience in life science and a strong interest in strategy and business development. He is pursuing a B.Sc. in International Business at CBS, with a focus on market entry and growth topics within the life sciences sector.